How Many Cancer Patients Use Complementary and Alternative Medicine
How Many Cancer Patients Use Complementary and Alternative Medicine
复制标题
有多少癌症患者使用补充和替代医学
DOI：
--
复制
发表时间：
2012
影响因子：
2.9
通讯作者：
M. Zwahlen
中科院分区：
文献类型：
--
作者：
M. Horneber;Gerd Bueschel;G. Dennert;Danuta Less;Erik Ritter;M. Zwahlen
背景自1998年以来，没有关于癌症患者使用补充和替代医学（CAM）频率的全面系统性综述。方法.检索MEDLINE、AMED和Embase数据库中截至2009年1月发表的调查。在澳大利亚、加拿大、欧洲、新西兰和美国进行的调查包括至少100名成年癌症患者。方法和结果的详细信息由2名评审员独立提取。使用根据STROBE指南制定的标准列表评估方法学质量。采用探索性随机效应荟萃分析和荟萃回归分析。结果纳入了来自18个国家（152; >65，000名癌症患者）的研究。CAM使用的异质性很高，在一定程度上解释了调查方法的差异。所有研究中“目前使用”CAM的合并患病率为40%。最高的是美国，最低的是意大利和荷兰。荟萃分析表明，CAM的使用从20世纪70年代和80年代的估计25%增加到20世纪90年代的32%以上，2000年后增加到49%。结论. CAM使用的总体流行率低于通常声称的水平。然而，有一些证据表明，过去几年来，使用量大幅增加。因此，卫生保健系统应该实施明确的战略，如何处理这一问题。为了提高未来调查的有效性和报告，作者提出了应满足的方法质量标准和应要求的报告标准。
Background. No comprehensive systematic review has been published since 1998 about the frequency with which cancer patients use complementary and alternative medicine (CAM). Methods. MEDLINE, AMED, and Embase databases were searched for surveys published until January 2009. Surveys conducted in Australia, Canada, Europe, New Zealand, and the United States with at least 100 adult cancer patients were included. Detailed information on methods and results was independently extracted by 2 reviewers. Methodological quality was assessed using a criteria list developed according to the STROBE guideline. Exploratory random effects metaanalysis and metaregression were applied. Results. Studies from 18 countries (152; >65 000 cancer patients) were included. Heterogeneity of CAM use was high and to some extent explained by differences in survey methods. The combined prevalence for “current use” of CAM across all studies was 40%. The highest was in the United States and the lowest in Italy and the Netherlands. Metaanalysis suggested an increase in CAM use from an estimated 25% in the 1970s and 1980s to more than 32% in the 1990s and to 49% after 2000. Conclusions. The overall prevalence of CAM use found was lower than often claimed. However, there was some evidence that the use has increased considerably over the past years. Therefore, the health care systems ought to implement clear strategies of how to deal with this. To improve the validity and reporting of future surveys, the authors suggest criteria for methodological quality that should be fulfilled and reporting standards that should be required.
登录
查看更多内容
预测在早期乳腺癌患者的多种族样本中使用补充疗法的因素。
DOI：
--
发表时间：
2001
期刊：
Journal of the American Medical Women's Association (1972)
影响因子：
--
作者：
Alferi,SM;Antoni,MH;Ironson,G;Kilbourn,KM;Carver,CS
通讯作者：
Carver,CS
参与癌症临床试验的成年患者使用补充药物。
影响因子：
1.9
作者：
Sparber,A;Bauer,L;Curt,G;Eisenberg,D;Levin,T;Parks,S;Steinberg,SM;Wootton,J
通讯作者：
Wootton,J
影响因子：
158.5
作者：
Burstein, HJ;Gelber, S;Weeks, JC
通讯作者：
Weeks, JC
DOI：
--
发表时间：
2003-01
期刊：
The New Zealand medical journal
影响因子：
--
作者：
K. Chrystal;S. Allan;G. Forgeson;R. Isaacs
通讯作者：
K. Chrystal;S. Allan;G. Forgeson;R. Isaacs
在夏威夷癌症患者中使用补充和替代医学。
DOI：
--
发表时间：
1999
期刊：
Hawaii medical journal.
影响因子：
--
作者：
Gotay,CC
通讯作者：
Gotay,CC